During the past decade, Lipidklinikken - Rikshospitalet conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lipidklinikken - Rikshospitalet" #1 collaborator was "Beijing Peking University WBL Biotech Co., Ltd." with 1 trials as a collaborator, "Mills DA" with 1 trials as a collaborator, "Pharma Nord" with 1 trials as a collaborator, "Pharmalogica" with 1 trials as a collaborator and "University of Oslo School of Pharmacy" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lipidklinikken - Rikshospitalet" are "Familial Hypercholesterolemia" (2 trials), "Glucose Metabolism Disorders" (1 trials), "High Blood Cholesterol Level" (1 trials), "Hyperlipidemia" (1 trials) and "Hypertriglyceridemia" (1 trials). Many other conditions were trialed in "Lipidklinikken - Rikshospitalet" in a lesser frequency.

Most popular intervention types in "Lipidklinikken - Rikshospitalet" are "Drug" (6 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Implitapide" (2 trials), "HYPOCOL®" (1 trials), "Intake of plant sterols" (1 trials), "Q10" (1 trials) and "Selen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lipidklinikken - Rikshospitalet" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Lipidklinikken - Rikshospitalet". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lipidklinikken - Rikshospitalet, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Lipidklinikken - Rikshospitalet, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".